RSS   Newsletter   Contact   Advertise with us
Post Online Media

Jerome Zeldis to join Sorrento

Jerome ZeldisSorrento Therapeutics, a clinical-stage biopharmaceutical company, appointed Jerome Zeldis to the position of chief medical officer and president of clinical development.
Article continues below

READ MORE MetaStat appoints Jerome B. Zeldis as vice chairman

Dr. Zeldis joins Sorrento after a nearly 20-year career at Celgene. Most recently, Dr. Zeldis held the position of Chief Executive Officer of Celgene Global Health and Chief Medical Officer of Celgene.

Prior to Celgene, Dr. Zeldis was the Associate Director of Clinical Research at Sandoz Research Institute and the Director of Medical Development at Janssen Pharmaceutical Research Institute.

Dr. Zeldis received his medical training in Internal Medicine at the UCLA Center for the Health Sciences and was a clinical and research fellow in gastroenterology at Massachusetts General Hospital and Harvard Medical School.

Additionally, he served as an Assistant Professor of Medicine at Harvard Medical School, an Associate Professor of Medicine at the University of California, a Clinical Associate Professor of Medicine at Cornell Medical School, and a Professor of Clinical Medicine at the Robert Wood Johnson Medical School in New Brunswick, N.J.

Dr. Zeldis holds BA and MS degrees from Brown University, and M.Phil., M.D., and Ph.D. degrees from Yale University.

He has published 122 peer-reviewed articles and is a named inventor on 43 US patents.

He currently serves as Chairman of the board of Alliqua, Semorex, and Trek Therapeutics, Vice Chairman of MetaStat and serves on the boards of Kalytera Therapeutics, BioSig Technologies, IR Biosciences Holdings, PTC Therapeutics, and Soligenix.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy